<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN"
        "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article         dtd-version="1.4">
            <front>

                <journal-meta>
                                    <journal-id></journal-id>
            <journal-title-group>
                                                                                    <journal-title>Cell Membranes and Free Radical Research</journal-title>
            </journal-title-group>
                            <issn pub-type="ppub">1308-416X</issn>
                                                                                                        <publisher>
                    <publisher-name>Hücresel Sinir Bilimleri ve Oksidatif Stres Derneği</publisher-name>
                </publisher>
                    </journal-meta>
                <article-meta>
                                        <article-id/>
                                                                                                                                                                                            <title-group>
                                                                                                                        <article-title>Adenosine deaminase and Guanase deaminase activities in serum of patients with rheumatoid Arthritis</article-title>
                                                                                                                                        </title-group>
            
                                                    <contrib-group content-type="authors">
                                                                        <contrib contrib-type="author">
                                                                <name>
                                    <surname>Onal</surname>
                                    <given-names>Suleyman</given-names>
                                </name>
                                                            </contrib>
                                                                                </contrib-group>
                        
                                        <pub-date pub-type="pub" iso-8601-date="20130814">
                    <day>08</day>
                    <month>14</month>
                    <year>2013</year>
                </pub-date>
                                        <volume>4</volume>
                                        <issue>3</issue>
                                        <fpage>215</fpage>
                                        <lpage>219</lpage>
                        
                        <history>
                                    <date date-type="received" iso-8601-date="20130814">
                        <day>08</day>
                        <month>14</month>
                        <year>2013</year>
                    </date>
                                            </history>
                                        <permissions>
                    <copyright-statement>Copyright © 2008, Cell Membranes and Free Radical Research</copyright-statement>
                    <copyright-year>2008</copyright-year>
                    <copyright-holder>Cell Membranes and Free Radical Research</copyright-holder>
                </permissions>
            
                                                                                                <abstract><p>We investigated purin and primidin salvage pathways inrheumatoid arthritis (RA). For the aim, Adenosine deaminase(AD) and Guanosine deaminase (GD) activities in serum ofpatients with di!erent manifestations of the disease (n=32) wereinvestigated and compared with the control group of healthyindividuals (n=52). RA cases were classified with respect to theirclinics and treatment.The ADA activities were significantly higher (p</p></abstract>
                                                                                    
            
                                                            <kwd-group>
                                                    <kwd>-</kwd>
                                            </kwd-group>
                                                        
                                                                                                                                                    </article-meta>
    </front>
    <back>
                            <ref-list>
                                    <ref id="ref1">
                        <label>1</label>
                        <mixed-citation publication-type="journal">Antonioli L, Colucci R, La Motta C, Tuccori M, Awwad O, Da Settimo F, Blandizzi C, Fornai M. 2012. Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders. Curr Drug Targets. 13(6):842-162.</mixed-citation>
                    </ref>
                                    <ref id="ref2">
                        <label>2</label>
                        <mixed-citation publication-type="journal">Arnett FC, Edworthy SM, Bloch DA. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324.</mixed-citation>
                    </ref>
                                    <ref id="ref3">
                        <label>3</label>
                        <mixed-citation publication-type="journal">Bukulmez G, Akan T, Ciliu G. 2000. Serum adenosine deaminase levels in patients with psoriasis: a prospective case-control study. Eur J dermatol 10: 274-276.</mixed-citation>
                    </ref>
                                    <ref id="ref4">
                        <label>4</label>
                        <mixed-citation publication-type="journal">Erel O, Kocyigit A, Gurel MS, Bulut V, Seyrek A, Ozdemir Y. 1998. Adenosine deaminase activities in sera, lymphocytes and granulocytes in patients with Cutaneous Leishmaniasis. Mem Inst Oswaldo Cruz 93: 491-494.</mixed-citation>
                    </ref>
                                    <ref id="ref5">
                        <label>5</label>
                        <mixed-citation publication-type="journal">Erkiliç K, Evereklioglu C, Cekmen M, Ozkiris A, Duygulu F, Dogan H. 2003. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet&#039;s disease: original contributions/clinical and laboratory investigations. Mediators Inflamm 12:107-16.</mixed-citation>
                    </ref>
                                    <ref id="ref6">
                        <label>6</label>
                        <mixed-citation publication-type="journal">Fox IH, Kelley WN 1978. The role of adenosine deaminase and 2&#039;-deoxyadenosine in mammalian cells. Ann Rev Biochem 47: 655-686.</mixed-citation>
                    </ref>
                                    <ref id="ref7">
                        <label>7</label>
                        <mixed-citation publication-type="journal">Gakis G, Calia GM, Naitana AG, Ortu AN, Contu A. 1991. Serum and pleural adenosine deaminase activity. Chest 99:1555-1556.</mixed-citation>
                    </ref>
                                    <ref id="ref8">
                        <label>8</label>
                        <mixed-citation publication-type="journal">Giusti G, Galanti B. 1984. Adenosine deaminase: colorimetric method, p. 315- 323. In HV Bergmeyer Methods of Enzymatic Analsis Academic Press, New York.</mixed-citation>
                    </ref>
                                    <ref id="ref9">
                        <label>9</label>
                        <mixed-citation publication-type="journal">Jones DD, Roberts EL, Davies AG. 1983. The estimation of serum guanosine deaminase activity in liver diseases. J Clin Chem Biochem 21: 835-840.</mixed-citation>
                    </ref>
                                    <ref id="ref10">
                        <label>10</label>
                        <mixed-citation publication-type="journal">Kamanlı A, Nazıroğlu M, Aydilek N, Hacıevliyagil C. 2004. Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem Funct. 22:53-57.</mixed-citation>
                    </ref>
                                    <ref id="ref11">
                        <label>11</label>
                        <mixed-citation publication-type="journal">Katchamart W, Johnson S, Lin HJ, Phumethum V, Salliot C, Bombardier C. 2010. Predictors for remission in rheumatoid arthritis patients: A systematic review. Arthritis Care Res (Hoboken). 62(8):1128-1143.</mixed-citation>
                    </ref>
                                    <ref id="ref12">
                        <label>12</label>
                        <mixed-citation publication-type="journal">Klarenbeek NB, Allaart CF, Kerstens PJ, Huizinga TW, Dijkmans BA. 2009. The best story: on strategy trials in rheumatoid arthritis. Curr Opin Rheumatol. 21:291-298.</mixed-citation>
                    </ref>
                                    <ref id="ref13">
                        <label>13</label>
                        <mixed-citation publication-type="journal">Kobayashi F, Ikeda T, Marumo F, Sato C. 1993. Adenosine deaminase isoenzymes in liver disease, Am J Gastroenterol 88:266-271.</mixed-citation>
                    </ref>
                                    <ref id="ref14">
                        <label>14</label>
                        <mixed-citation publication-type="journal">Le NT, Xue M, Castelnoble LA, Jackson CJ. 2007. The dual personalities of matrix metalloproteinases in inflammation. Front Biosci. 12:1475-1487.</mixed-citation>
                    </ref>
                                    <ref id="ref15">
                        <label>15</label>
                        <mixed-citation publication-type="journal">Nardiello S, Russo M, Pizzella T, Galanti B. 1983. Di&quot;erent levels of lymphocyte adenosine deaminase in active and inactive forms of chronic liver disease. J Clin Lab Immunol 11:177-180.</mixed-citation>
                    </ref>
                                    <ref id="ref16">
                        <label>16</label>
                        <mixed-citation publication-type="journal">Onal S, Nazıroğlu M, Colak M, Bulut V, Flores-Arce MF. 2011. E&quot;ects of di&quot;erent medical treatments on serum copper, selenium and zinc levels in patients with rheumatoid arthritis. Biol Trace Elem Res. 142(3):447-55.</mixed-citation>
                    </ref>
                                    <ref id="ref17">
                        <label>17</label>
                        <mixed-citation publication-type="journal">Sullivan J, Osborne WR, Wedgewood RJ. 1977. Adenosine deaminase activity in lymphocytes. Br J Haematol 37: 157-158.</mixed-citation>
                    </ref>
                                    <ref id="ref18">
                        <label>18</label>
                        <mixed-citation publication-type="journal">Ungerer JP, Burger HM, Bissbort SH, Vermaak WJ. 1996. Adenosine deaminase isoenzymes in typhoid fever. Eur J Clin Microbiol Infect Dis 15: 510-512.</mixed-citation>
                    </ref>
                                    <ref id="ref19">
                        <label>19</label>
                        <mixed-citation publication-type="journal">Valls V, Ena J, Roca V, Perez-Oteyza C, Angeles Figueredo M, Enriquez-deSalamanca R. 1990. Significance of adenosine deaminase measurement in sera of patients with HIV-1 infection. AIDS 4: 365-366.</mixed-citation>
                    </ref>
                                    <ref id="ref20">
                        <label>20</label>
                        <mixed-citation publication-type="journal">Van Linden A, Eltzschig HK. 2007. Role of pulmonary adenosine during hypoxia: extracellular generation, signaling and metabolism by surface adenosine deaminase/CD26. Expert Opin Biol Ther. 7(9):1437-47.</mixed-citation>
                    </ref>
                                    <ref id="ref21">
                        <label>21</label>
                        <mixed-citation publication-type="journal">Yazar M, Sarban S, Kocyigit A, Isikan UE. 2005. Synovial fluid and plasma selenium, copper, zinc, and iron concentrations in patients with rheumatoid arthritis and osteoarthritis. Biol Trace Elem Res. 106:123-132.</mixed-citation>
                    </ref>
                                    <ref id="ref22">
                        <label>22</label>
                        <mixed-citation publication-type="journal">Zakeri Z, Izadi S, Niazi A, Bari Z, Zendeboodi S, Shakiba M, Mashhadi M, Narouie B, Ghasemi-Rad M. 2012. Comparison of adenosine deaminase levels in serum and synovial fluid between patients with rheumatoid arthritis and osteoarthritis. Int J Clin Exp Med. 2012;5(2):195-200.</mixed-citation>
                    </ref>
                                    <ref id="ref23">
                        <label>23</label>
                        <mixed-citation publication-type="journal">Zamani B, Jamali R, Jamali A. 2012. Serum adenosine deaminase may predict disease activity in rheumatoid arthritis. Rheumatol Int. 32(7):1967-1975.</mixed-citation>
                    </ref>
                            </ref-list>
                    </back>
    </article>
